$APYP
APPYEA, INC

2019 Q2 Form 10-Q Financial Statement

#000164033419000847 Filed on May 14, 2019

View on sec.gov

Income Statement

Concept 2019 Q2 2019 Q1 2018 Q1
Revenue $0.00 $92.00 $11.80K
YoY Change -100.0% -99.22% 6528.65%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $40.00K $40.00K $130.0K
YoY Change -63.64% -69.23% -7.14%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00 $0.00 $6.500K
YoY Change -100.0% -39.86%
% of Gross Profit
Operating Expenses $30.00K $38.08K $136.4K
YoY Change -78.57% -72.08% -6.92%
Operating Profit -$37.99K -$124.6K
YoY Change -69.5% -14.87%
Interest Expense $1.870M $54.56K $112.9K
YoY Change -474.0% -51.69% 975.0%
% of Operating Profit
Other Income/Expense, Net -$2.850M -$272.5K
YoY Change 945.73% 5110.71%
Pretax Income $1.630M -$2.890M -$400.0K
YoY Change -350.77% 622.5% 166.67%
Income Tax
% Of Pretax Income
Net Earnings $1.630M -$2.888M -$397.1K
YoY Change -350.77% 627.24% 162.02%
Net Earnings / Revenue -3138917.39% -3365.45%
Basic Earnings Per Share
Diluted Earnings Per Share $0.07 -$0.22 -$0.07
COMMON SHARES
Basic Shares Outstanding 4.001B shares 2.150B shares 1.146B shares
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q2 2019 Q1 2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $50.00K $90.00K $0.00
YoY Change 0.0% -100.0%
Cash & Equivalents $45.06K $86.34K $1.258K
Short-Term Investments
Other Short-Term Assets $10.00K
YoY Change
Inventory
Prepaid Expenses $9.500K
Receivables $10.00K
Other Receivables $0.00
Total Short-Term Assets $54.56K $86.34K $12.90K
YoY Change 15.59% 569.32% -77.21%
LONG-TERM ASSETS
Property, Plant & Equipment $800.00 $13.80K
YoY Change -94.2% -72.32%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $24.52K
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $800.00 $38.32K
YoY Change -100.0% -97.91% -23.12%
TOTAL ASSETS
Total Short-Term Assets $54.56K $86.34K $12.90K
Total Long-Term Assets $0.00 $800.00 $38.32K
Total Assets $54.56K $87.14K $51.22K
YoY Change 0.11% 70.11% -51.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $40.00K $270.0K $200.0K
YoY Change -85.71% 35.0% 5084.03%
Accrued Expenses $2.496K $1.869K $200.0K
YoY Change 0.48% -99.07% 100.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $320.0K $280.0K $210.0K
YoY Change 6.67% 33.33% 10.53%
Total Short-Term Liabilities $1.030M $3.739M $1.270M
YoY Change -45.9% 194.33% 265.69%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.030M $3.739M $1.270M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.030M $3.739M $1.270M
YoY Change -45.9% 194.33% 265.69%
SHAREHOLDERS EQUITY
Retained Earnings -$7.842M -$9.475M -$6.124M
YoY Change 15.71% 54.72% 38.86%
Common Stock $509.6K $381.3K $116.8K
YoY Change 310.81% 226.34% 151.45%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$975.6K -$3.651M -$1.219M
YoY Change
Total Liabilities & Shareholders Equity $54.56K $87.14K $51.22K
YoY Change 0.11% 70.11% -51.88%

Cashflow Statement

Concept 2019 Q2 2019 Q1 2018 Q1
OPERATING ACTIVITIES
Net Income $1.630M -$2.888M -$397.1K
YoY Change -350.77% 627.24% 162.02%
Depreciation, Depletion And Amortization $0.00 $0.00 $6.500K
YoY Change -100.0% -39.86%
Cash From Operating Activities -$40.00K -$10.00K -$10.00K
YoY Change 300.0% 0.0% -90.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 10.00K 90.00K 0.000
YoY Change -83.33% -100.0%
NET CHANGE
Cash From Operating Activities -40.00K -10.00K -10.00K
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 10.00K 90.00K 0.000
Net Change In Cash -30.00K 80.00K -10.00K
YoY Change -160.0% -900.0% -200.0%
FREE CASH FLOW
Cash From Operating Activities -$40.00K -$10.00K -$10.00K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Registrant Name
EntityRegistrantName
APPYEA, INC
dei Entity Central Index Key
EntityCentralIndexKey
0001568969
dei Trading Symbol
TradingSymbol
apyp
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2019Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4001486092 shares
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2019-03-31
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
42567 usd
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
47196 usd
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
86335 usd
CY2018Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1258 usd
CY2018Q2 us-gaap Assets Current
AssetsCurrent
47196 usd
CY2019Q1 us-gaap Assets Current
AssetsCurrent
86335 usd
CY2018Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7300 usd
CY2019Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
800 usd
CY2018Q2 us-gaap Assets
Assets
54496 usd
CY2019Q1 us-gaap Assets
Assets
87135 usd
CY2018Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
275312 usd
CY2019Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
273119 usd
CY2018Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
224000 usd
CY2019Q1 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
291300 usd
CY2018Q2 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
290823 usd
CY2019Q1 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
283973 usd
CY2018Q2 apyp Convertible Debt Related Party
ConvertibleDebtRelatedParty
8977 usd
CY2018Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
88087 usd
CY2019Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
82749 usd
CY2018Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1016865 usd
CY2019Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
2807468 usd
CY2018Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1904064 usd
CY2019Q1 us-gaap Liabilities Current
LiabilitiesCurrent
3738609 usd
CY2018Q2 us-gaap Liabilities
Liabilities
1904064 usd
CY2019Q1 us-gaap Liabilities
Liabilities
3738609 usd
CY2018Q2 us-gaap Preferred Stock Value
PreferredStockValue
500 usd
CY2019Q1 us-gaap Preferred Stock Value
PreferredStockValue
500 usd
CY2018Q2 us-gaap Common Stock Value
CommonStockValue
124047 usd
CY2019Q1 us-gaap Common Stock Value
CommonStockValue
381304 usd
CY2018Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4740277 usd
CY2019Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5394439 usd
CY2018Q2 apyp Stock Payable Common Shares Value
StockPayableCommonSharesValue
62727 usd
CY2019Q1 apyp Stock Payable Common Shares Value
StockPayableCommonSharesValue
47727 usd
CY2018Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6777119 usd
CY2019Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9475444 usd
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
-415210 usd
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
-1849568 usd
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
-3651474 usd
CY2017Q3 us-gaap Stockholders Equity
StockholdersEquity
-615189 usd
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
-856012 usd
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
-1218989 usd
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
-2067144 usd
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-1536095 usd
CY2018Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
54496 usd
CY2019Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
87135 usd
CY2018Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
250570 usd
CY2019Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
257070 usd
CY2018Q2 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
81968 usd
CY2019Q1 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
108630 usd
CY2018Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2018Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
60000000 shares
CY2019Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
60000000 shares
CY2018Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
5000000 shares
CY2019Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
5000000 shares
CY2018Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
5000000 shares
CY2019Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
5000000 shares
CY2018Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
6000000000 shares
CY2019Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
6000000000 shares
CY2018Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1240477060 shares
CY2019Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3813044892 shares
CY2018Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1240477060 shares
CY2019Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3813044892 shares
CY2018Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
158 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1202 usd
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
92 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
289 usd
CY2018Q1 us-gaap Professional Fees
ProfessionalFees
103567 usd
us-gaap Professional Fees
ProfessionalFees
333371 usd
CY2019Q1 us-gaap Professional Fees
ProfessionalFees
7979 usd
us-gaap Professional Fees
ProfessionalFees
36150 usd
CY2018Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
26301 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
161397 usd
CY2019Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
30101 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
84770 usd
CY2018Q1 us-gaap Depreciation
Depreciation
6500 usd
us-gaap Depreciation
Depreciation
25244 usd
us-gaap Depreciation
Depreciation
6500 usd
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
136368 usd
us-gaap Operating Expenses
OperatingExpenses
520012 usd
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
38080 usd
us-gaap Operating Expenses
OperatingExpenses
127420 usd
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-124569 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-507169 usd
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-37988 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-127131 usd
CY2018Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-159104 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-509092 usd
CY2019Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-2795259 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-2439934 usd
CY2018Q1 us-gaap Interest Expense
InterestExpense
112940 usd
us-gaap Interest Expense
InterestExpense
324496 usd
CY2019Q1 us-gaap Interest Expense
InterestExpense
54557 usd
us-gaap Interest Expense
InterestExpense
131260 usd
CY2018Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-272520 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-834064 usd
CY2019Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2849816 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2571194 usd
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-406633 usd
CY2017Q4 us-gaap Net Income Loss
NetIncomeLoss
-537511 usd
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-397089 usd
us-gaap Net Income Loss
NetIncomeLoss
-1341233 usd
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-217576 usd
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
407055 usd
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-2887804 usd
us-gaap Net Income Loss
NetIncomeLoss
-2698325 usd
apyp Common Stock Issued For Services
CommonStockIssuedForServices
99500 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
273744 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
78338 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
192078 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2193 usd
us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
72000 usd
us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
67300 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
50752 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
52923 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-129988 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-55523 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
25000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-25000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
200 usd
apyp Proceeds From Convertible Notes Payable Net Of Original Issue Discounts
ProceedsFromConvertibleNotesPayableNetOfOriginalIssueDiscounts
91667 usd
apyp Proceeds From Convertible Notes Payable Net Of Original Issue Discounts
ProceedsFromConvertibleNotesPayableNetOfOriginalIssueDiscounts
100000 usd
apyp Proceeds From Convertible Notes Payable Related Party
ProceedsFromConvertibleNotesPayableRelatedParty
8333 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
20050 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
4256 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
6571 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
9594 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
113679 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
94662 usd
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-41309 usd
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
39139 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
apyp Issuance Of Common Stock For Conversion Of Debt And Accrued Interest
IssuanceOfCommonStockForConversionOfDebtAndAccruedInterest
156331 usd
apyp Issuance Of Common Stock For Conversion Of Debt And Accrued Interest
IssuanceOfCommonStockForConversionOfDebtAndAccruedInterest
147088 usd
us-gaap Notes Reduction
NotesReduction
281424 usd
us-gaap Notes Reduction
NotesReduction
734331 usd
apyp Derivative Liability Recognized As Debt Discount
DerivativeLiabilityRecognizedAsDebtDiscount
235000 usd
apyp Derivative Liability Recognized As Debt Discount
DerivativeLiabilityRecognizedAsDebtDiscount
100000 usd
us-gaap Nature Of Operations
NatureOfOperations
<p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: times new roman,times;" size="2"><b>1. NATURE OF OPERATIONS</b></font></p> <p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: times new roman,times;" size="2">&#160;</font></p> <p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: times new roman,times;" size="2">AppYea, Inc. ("AppYea", "the Company", "we" or "us") was incorporated in the State of South Dakota on November 26, 2012 to engage in the acquisition, purchase, maintenance and creation of mobile software applications. The Company is in the development stage with no significant revenues and a limited operating history.</font></p> <p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: times new roman,times;" size="2">&#160;</font></p> <p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: times new roman,times;" size="2">The Company incorporated a wholly-owned subsidiary, &#8220;AppYea Holdings, Inc.&#8221; in state of South Dakota on January 13, 2017 and "The Diagnostic Centers Inc." in State of South Dakota on August 2, 2017.</font></p> <p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: times new roman,times;" size="2">&#160;</font></p> <p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: times new roman,times;" size="2">Through its wholly owned subsidiary, The Diagnostic Centers, Inc., AppYea markets comprehensive diagnostic testing services to physician offices, clinics, hospitals, long term care facilities, healthcare groups, and other healthcare providers.</font></p> <p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p align="justify" style="margin: 0px;"><font style="font-family: times new roman,times;" size="2">During the quarter ended March 31, 2019 the Company entered into a management and advisory agreement with Hempori, Inc. to assist the Company in identifying and managing the Company&#8217;s overall business strategy and opportunities to enter the hemp based Cannabidiol (CBD) industry. Additionally, the Company entered into an exclusive CBD infused beverage licensing agreement with the Prouty Company to market flavored and non-flavored beverages in various formulas infused with CBD to achieve the following &#8220;mood enhancing&#8221; affects: Energy, Calm, Focus, and Sleep.</font></p> <p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: times new roman,times;" size="2">&#160;</font></p> <p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: times new roman,times;" size="2">The Company's common stock is traded on the OTC Markets (www.otcmarkets.com) under the symbol "APYP". The first day of trading on the OTC Markets was December 15, 2014.</font></p>
us-gaap Use Of Estimates
UseOfEstimates
<p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><b>Use of Estimates</b></p> <p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The preparation of financial statements in accordance with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include assumptions about the valuation and recognition of stock-based compensation expense, the valuation and recognition of derivative liability, valuation allowance for deferred tax assets and useful life of fixed assets.</p>
CY2019Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
295541 usd
CY2019Q1 apyp Working Capital Surplus Deficit
WorkingCapitalSurplusDeficit
-3652274 usd
CY2018Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
257870 usd
CY2019Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
257870 usd
CY2018Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
345614 usd
CY2019Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
366642 usd
CY2018Q2 us-gaap Interest Payable Current
InterestPayableCurrent
27177 usd
CY2019Q1 us-gaap Interest Payable Current
InterestPayableCurrent
25961 usd
CY2018Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
290823 usd
CY2019Q1 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
283973 usd
CY2018Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
290823 usd
CY2019Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
283973 usd
CY2018Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
0 usd
CY2019Q1 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
0 usd
CY2018Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
592916818 shares
CY2019Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
592916818 shares
apyp Class Of Warrant Or Right Granted
ClassOfWarrantOrRightGranted
0 shares
apyp Class Of Warrant Or Right With Reset Feature
ClassOfWarrantOrRightWithResetFeature
0 shares
apyp Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
0 shares
apyp Class Of Warrant Or Right Forfeited Or Cancellation
ClassOfWarrantOrRightForfeitedOrCancellation
0 shares
CY2018Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.0004
CY2019Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.0004
apyp Class Of Warrant Or Right Weighted Average Exercise Price Granted
ClassOfWarrantOrRightWeightedAverageExercisePriceGranted
0
apyp Class Of Warrant Or Right Weighted Average Exercise Price With Reset Feature
ClassOfWarrantOrRightWeightedAverageExercisePriceWithResetFeature
0
apyp Class Of Warrant Or Right Weighted Average Exercise Price Exercised
ClassOfWarrantOrRightWeightedAverageExercisePriceExercised
0
apyp Class Of Warrant Or Right Weighted Average Exercise Price Forfeited Or Canceled
ClassOfWarrantOrRightWeightedAverageExercisePriceForfeitedOrCanceled
0
apyp Warrants Outstanding Weighted Average Remaining Contractual Life
WarrantsOutstandingWeightedAverageRemainingContractualLife
P2Y7M24D
apyp Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
592916818 shares
CY2019Q1 apyp Class Of Warrant Or Right Weighted Average Exercise Price
ClassOfWarrantOrRightWeightedAverageExercisePrice
0.0004
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
266157 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
78338 usd
CY2018Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
78947 usd
CY2018Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0500 pure
CY2018Q2 us-gaap Debt Instrument Convertible Threshold Trading Days
DebtInstrumentConvertibleThresholdTradingDays
20 day
CY2018Q2 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.0002
us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
2390969927 shares
us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
703852 usd
CY2018 us-gaap Debt Instrument Term
DebtInstrumentTerm
P6M
CY2018Q2 us-gaap Debt Default Longterm Debt Amount
DebtDefaultLongtermDebtAmount
54693 usd
CY2019Q1 us-gaap Debt Default Longterm Debt Amount
DebtDefaultLongtermDebtAmount
50000000 usd
CY2018 apyp Original Issue Discounts And Financing Costs
OriginalIssueDiscountsAndFinancingCosts
38447 usd
apyp Original Issue Discounts And Financing Costs
OriginalIssueDiscountsAndFinancingCosts
5000 usd
CY2018 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
142167 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
100000 usd
CY2018Q2 apyp Class Of Warrant Or Right Exercisable Of Common Stock Shares
ClassOfWarrantOrRightExercisableOfCommonStockShares
394735000 shares
CY2018Q2 us-gaap Derivative Net Liability Position Aggregate Fair Value
DerivativeNetLiabilityPositionAggregateFairValue
9371 usd
us-gaap Derivative Loss On Derivative
DerivativeLossOnDerivative
1038 usd
CY2018Q2 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
8333 usd
CY2019Q1 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
0 usd
CY2018Q2 us-gaap Notes Payable
NotesPayable
8333 usd
CY2019Q1 us-gaap Notes Payable
NotesPayable
0 usd
CY2018Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
644 usd
CY2019Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
0 usd
CY2018Q2 apyp Debt Instrument Unamortized Discount Related Party Current
DebtInstrumentUnamortizedDiscountRelatedPartyCurrent
0 usd
CY2019Q1 apyp Debt Instrument Unamortized Discount Related Party Current
DebtInstrumentUnamortizedDiscountRelatedPartyCurrent
0 usd
CY2018Q2 apyp Convertible Debt Related Party Current And Noncurrent
ConvertibleDebtRelatedPartyCurrentAndNoncurrent
8977 usd
CY2019Q1 apyp Convertible Debt Related Party Current And Noncurrent
ConvertibleDebtRelatedPartyCurrentAndNoncurrent
0 usd
CY2018Q2 apyp Convertible Debt Related Party Noncurrent
ConvertibleDebtRelatedPartyNoncurrent
0 usd
CY2019Q1 apyp Convertible Debt Related Party Noncurrent
ConvertibleDebtRelatedPartyNoncurrent
0 usd
CY2018 apyp Proceeds From Convertible Notes Payable Related Party Net Of Original Issue Discounts
ProceedsFromConvertibleNotesPayableRelatedPartyNetOfOriginalIssueDiscounts
8333 usd
CY2018 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.08 pure
CY2018 us-gaap Debt Conversion Converted Instrument Rate
DebtConversionConvertedInstrumentRate
0.45 pure
CY2019Q1 apyp Value Assigned To Derivative Liability Recognized As Debt Discount
ValueAssignedToDerivativeLiabilityRecognizedAsDebtDiscount
8333 usd
apyp Derivative Liabilities Settled On Issuance Of Common Stock
DerivativeLiabilitiesSettledOnIssuanceOfCommonStock
-734331 usd
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
2137896 usd
CY2018Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1863 usd
CY2019Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1869 usd
CY2013Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
200 usd
CY2013Q1 us-gaap Lessor Operating Lease Term Of Contract
LessorOperatingLeaseTermOfContract
P3M
CY2013Q1 us-gaap Description Of Lessee Leasing Arrangements Operating Leases
DescriptionOfLesseeLeasingArrangementsOperatingLeases
three-month periods unless there is the notice to cancel. The lease can be cancelled at any time by either party with 30 days' notice prior to expiration of an applicable term.
CY2019Q1 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
1500 shares
us-gaap Preferred Stock Voting Rights
PreferredStockVotingRights
voting rights of 1,000 shares of common stock
CY2017Q2 apyp Stock Payable To Consulting Services Common Shares Value
StockPayableToConsultingServicesCommonSharesValue
105000 usd
CY2019Q1 apyp Stock Payable To Consulting Services Common Shares Value
StockPayableToConsultingServicesCommonSharesValue
47727 usd
CY2017Q2 apyp Stock Issued During Period Shares Issuable For Consulting Services
StockIssuedDuringPeriodSharesIssuableForConsultingServices
55000000 shares
CY2018Q2 apyp Stock Issued During Period Shares Issuable For Consulting Services
StockIssuedDuringPeriodSharesIssuableForConsultingServices
10000000 shares
CY2019Q1 apyp Stock Issued During Period Shares Issuable For Consulting Services
StockIssuedDuringPeriodSharesIssuableForConsultingServices
25000000 shares
CY2018 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
30000000 shares
CY2018 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
200 usd
CY2018 apyp Stock Issued Period For Common Stock Payable
StockIssuedPeriodForCommonStockPayable
57273 usd
CY2017Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
99500 usd
CY2018 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
5000 usd
CY2018Q1 apyp Related Party Revenues
RelatedPartyRevenues
11641 usd
apyp Related Party Revenues
RelatedPartyRevenues
11641 usd
CY2018Q1 us-gaap Revenues
Revenues
11799 usd
us-gaap Revenues
Revenues
12843 usd
CY2019Q1 us-gaap Revenues
Revenues
92 usd
us-gaap Revenues
Revenues
289 usd
CY2018Q1 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
-476 usd
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
-476 usd
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2018Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1133230709 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
913338132 shares
CY2019Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2584304736 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1712269347 shares
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
10158 usd
us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
101597905 shares
apyp Derivative Liability Settled Through Additional Paid In Capital
DerivativeLiabilitySettledThroughAdditionalPaidInCapital
30479 usd
apyp Addition Of New Derivatives Recognized As Debt Discounts
AdditionOfNewDerivativesRecognizedAsDebtDiscounts
85000 usd
apyp Addition Of New Derivatives Recognized As Loss On Derivatives
AdditionOfNewDerivativesRecognizedAsLossOnDerivatives
302038 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
11641 usd
us-gaap Stock Issued1
StockIssued1
15000 usd
CY2017Q3 apyp Common Stock Issued Exchanged For Common Stock Payable
CommonStockIssuedExchangedForCommonStockPayable
200 usd
CY2017Q3 apyp Stock Issued During Period Value Common Stock Issued For Conversion Of Debt And Resolution Of Derivative Liabilities
StockIssuedDuringPeriodValueCommonStockIssuedForConversionOfDebtAndResolutionOfDerivativeLiabilities
206454 usd
CY2017Q4 apyp Stock Issued During Period Value Common Stock Issued For Conversion Of Debt And Resolution Of Derivative Liabilities
StockIssuedDuringPeriodValueCommonStockIssuedForConversionOfDebtAndResolutionOfDerivativeLiabilities
197188 usd
CY2018Q1 apyp Stock Issued During Period Value Common Stock Issued For Conversion Of Debt And Resolution Of Derivative Liabilities
StockIssuedDuringPeriodValueCommonStockIssuedForConversionOfDebtAndResolutionOfDerivativeLiabilities
34112 usd
CY2018Q4 apyp Stock Issued During Period Value Common Stock Issued For Conversion Of Debt And Resolution Of Derivative Liabilities
StockIssuedDuringPeriodValueCommonStockIssuedForConversionOfDebtAndResolutionOfDerivativeLiabilities
123994 usd
CY2019Q1 apyp Stock Issued During Period Value Common Stock Issued For Conversion Of Debt And Resolution Of Derivative Liabilities
StockIssuedDuringPeriodValueCommonStockIssuedForConversionOfDebtAndResolutionOfDerivativeLiabilities
757425 usd
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
136930 usd
CY2019Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
15000 usd
CY2019Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
30000000 shares
CY2018Q2 apyp Debt Instrument Interest Rate Default Percentage
DebtInstrumentInterestRateDefaultPercentage
0.2400 pure

Files In Submission

Name View Source Status
0001640334-19-000847-index-headers.html Edgar Link pending
0001640334-19-000847-index.html Edgar Link pending
0001640334-19-000847.txt Edgar Link pending
0001640334-19-000847-xbrl.zip Edgar Link pending
apyp-20190331.xsd Edgar Link pending
apyp_10q.htm Edgar Link pending
apyp_ex311.htm Edgar Link pending
apyp_ex321.htm Edgar Link pending
apyp-20190331_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
apyp-20190331_pre.xml Edgar Link unprocessable
apyp-20190331_lab.xml Edgar Link unprocessable
apyp-20190331.xml Edgar Link completed
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
apyp-20190331_cal.xml Edgar Link unprocessable